146 related articles for article (PubMed ID: 16803499)
21. Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.
Wagenaar HC; Pecorelli S; Mangioni C; van der Burg ME; Rotmensz N; Anastasopoulou A; Zola P; Veenhof CH; Lacave AJ; Neijt JP; van Oosterom AT; Einhorn N; Vermorken JB
Eur J Cancer; 2001 Sep; 37(13):1624-8. PubMed ID: 11527687
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer.
Maluf FC; Leiser AL; Aghajanian C; Sabbatini P; Pezzulli S; Chi DS; Wolf JK; Levenback C; Loh E; Spriggs DR
Int J Gynecol Cancer; 2006; 16(3):1165-71. PubMed ID: 16803501
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix.
van Luijk IF; Coens C; van der Burg ME; Kobierska A; Namer M; Lhomme C; Zola P; Zanetta G; Vermorken JB;
Ann Oncol; 2007 Feb; 18(2):275-81. PubMed ID: 17060485
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix.
Coleman RE; Clarke JM; Slevin ML; Sweetenham J; Williams CJ; Blake P; Calman F; Wiltshaw E; Harper PG
Cancer Chemother Pharmacol; 1990; 27(1):52-4. PubMed ID: 2245492
[TBL] [Abstract][Full Text] [Related]
26. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer.
Buxton EJ; Meanwell CA; Hilton C; Mould JJ; Spooner D; Chetiyawardana A; Latief T; Paterson M; Redman CW; Luesley DM
J Natl Cancer Inst; 1989 Mar; 81(5):359-61. PubMed ID: 2464699
[TBL] [Abstract][Full Text] [Related]
27. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
28. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
Bloss JD; Blessing JA; Behrens BC; Mannel RS; Rader JS; Sood AK; Markman M; Benda J
J Clin Oncol; 2002 Apr; 20(7):1832-7. PubMed ID: 11919241
[TBL] [Abstract][Full Text] [Related]
29. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of cisplatin and cyclophosphamide combination for recurrent and metastatic carcinoma of the uterine cervix.
Eralp Y; Saip P; Sakar B; Tas F; Aydiner A; Topuz E
Eur J Gynaecol Oncol; 2003; 24(3-4):323-6. PubMed ID: 12807249
[TBL] [Abstract][Full Text] [Related]
31. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
Windschall A; Ott OJ; Sauer R; Strnad V
Strahlenther Onkol; 2005 Aug; 181(8):545-50. PubMed ID: 16044224
[TBL] [Abstract][Full Text] [Related]
32. Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival.
Darnton SJ; Archer VR; Stocken DD; Mulholland PJ; Casson AG; Ferry DR
J Clin Oncol; 2003 Nov; 21(21):4009-15. PubMed ID: 14581424
[TBL] [Abstract][Full Text] [Related]
33. Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/ 5-fluorouracil in recurrent cervical cancer.
Cadron I; Jakobsen A; Vergote I
Gynecol Obstet Invest; 2005; 59(3):126-9. PubMed ID: 15604591
[TBL] [Abstract][Full Text] [Related]
34. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. A phase II trial.
Cervellino JC; Araujo CE; Sánchez O; Miles H; Nishihama A
Acta Oncol; 1995; 34(2):257-9. PubMed ID: 7718266
[TBL] [Abstract][Full Text] [Related]
36. A phase II trial of ifosfamide, 5-fluorouracil, and leucovorin in recurrent uterine cervical cancer.
Stornes I; Mejlholm I; Jakobsen A
Gynecol Oncol; 1994 Oct; 55(1):123-5. PubMed ID: 7959252
[TBL] [Abstract][Full Text] [Related]
37. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Sculier JP; Lafitte JJ; Paesmans M; Thiriaux J; Alexopoulos CG; Baumöhl J; Schmerber J; Koumakis G; Florin MC; Zacharias C; Berghmans T; Mommen P; Ninane V; Klastersky J
Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Omura GA; Blessing JA; Vaccarello L; Berman ML; Clarke-Pearson DL; Mutch DG; Anderson B
J Clin Oncol; 1997 Jan; 15(1):165-71. PubMed ID: 8996138
[TBL] [Abstract][Full Text] [Related]
39. Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study.
Zanaboni F; Grijuela B; Giudici S; Cormio G; Babilonti L; Ghezzi F; Giorda G; Scambia G; Franchi M; Lorusso M; Ditto A; Lorusso D; Raspagliesi F
Eur J Cancer; 2013 Mar; 49(5):1065-72. PubMed ID: 23151423
[TBL] [Abstract][Full Text] [Related]
40. Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer.
Shimada M; Sato S; Oishi T; Itamochi H; Kigawa J; Takeshima N; Aoki D; Aoki Y; Nambu Y; Ochiai K
Int J Clin Oncol; 2016 Oct; 21(5):969-974. PubMed ID: 27142771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]